Please ensure Javascript is enabled for purposes of website accessibility

Live: Coronavirus Market Crash Coverage

The Motley Fool’s live guide on what investors should do during the stock market crash and the COVID-19 pandemic.

We’ve created this page for all investors seeking advice on what they should be doing in this turbulent period. Our most important content can be found in the Editors' Picks, section.

We do believe this will all end up behind us, because we view investing as a long-term endeavor. Borrowing from Warren Buffett: "We have no idea -- and never have had -- whether the market is going to go up, down, or sideways in the near- or intermediate-term future." However, we firmly believe investors will be rewarded over the long term.

We suggest bookmarking this page as we will update our Editors' Picks periodically -- the Recent Articles section is a live feed of our latest thinking. Finally, we understand that many people are seeking epidemiological information on COVID-19. For that we strictly suggest visiting the information pages set up by the CDC and WHO.

For members of The Motley Fool's investing services, you can access all our Coronavirus market coverage at fool.com/premium after logging in.

Recent articles

Vaccine shot

Does Ocugen Have a Real Shot at the U.S. COVID Vaccine Market?

The biotech faces some big challenges.


Coronavirus and $100 bills

Better Vaccine Stock: Ocugen or Vaxart?

Here's how the biotechs compare on several key fronts.


European Union map with coronavirus

Why is the EU Suing AstraZeneca?

The EU doesn't think the big drugmaker has held up its end of a supply agreement.


Vaccine being given to teen boy

Why BioNTech Stock Is Jumping Again Today

Health Canada authorized the company's COVID-19 vaccine for kids ages 12 to 15.


Physician holding a vaccine shot

Should Pfizer and Moderna Be Worried About This New COVID Vaccine Study?

Probably not, but the study could benefit another vaccine maker.


3 lines with arrows and dollar signs pointing up

Why Moderna Could Triple Its COVID Vaccine Sales Next Year

The biotech just provided a big clue that sales are poised to skyrocket.


Coronavirus stock chart down

Why BioNTech Stock Is Sinking Today

The culprits appear to be profit-taking investors and a broader market sell-off.


two female workers discuss behind a glass window in a lab

Is Emergent BioSolutions Still a Buy After Its Coronavirus Vaccine Flub?

Shareholders beware: The hits just won't stop coming.


young female healthcare worker in scrubs stands in the foreground at work

The End of the Pandemic Will Mean a Major Boost for These 2 Buy-and-Hold Stalwarts

People will be getting back to their regular routines when it comes to medical and dental care.


EU flag with syringe

Why Novavax Stock Is Sinking Today

Investors don't like the timing of a potential supply deal with the EU.


GettyImages-1159251941

Penn National Gaming Earnings: 1 Key Metric You'll Want to Know

The casino operator will report first-quarter results on May 6.


starbucksicedrink

Starbucks Is Raising Expectations for 2021

The international coffee chain reported second-quarter results on Tuesday, April 27.


Pizza Delivery

Here's the 1 Reason Yum China Is the Restaurant Growth Stock You Need

The pandemic is still hurting, but Yum China's massive digital business is thriving.


GettyImages-1133557365

Chegg Earnings: 1 Key Metric You'll Want to Know

The student learning services company reports first-quarter results on May 3.


GettyImages-1174957456

Activision Blizzard Earnings: 1 Key Metric You'll Want to Know

The video game company will report first-quarter earnings on Tuesday, May 4.


GettyImages-1254360836

Pinterest Continues Growing Revenue and Users

Shares of the social media company sink despite robust revenue growth.


GettyImages-1220006108

Clorox Earnings: 1 Key Metric You Should Know

The company will report fiscal 2021 third-quarter earnings on Friday, April 30.


GettyImages-1160129584

Royal Caribbean Earnings: 1 Key Metric You Should Know

The cruise ship operator will report first-quarter results on Thursday, April 29.


GettyImages-186543936

How an End to COVID-19 Will Help This E-Commerce Stock

This company will get a boost from economic normalization.


COVID vaccine with dollar sign

Why Moderna's Latest Supply Deal Could Make the Stock a Big Bargain Right Now

It might be a sign that even bigger deals are on the way.